Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000585110 | SCV000692600 | likely pathogenic | not provided | 2017-09-01 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV002248805 | SCV002518880 | pathogenic | Neuronopathy, distal hereditary motor, autosomal recessive 4 | 2022-05-04 | criteria provided, single submitter | clinical testing | |
MGZ Medical Genetics Center | RCV002289881 | SCV002580406 | likely pathogenic | Charcot-Marie-Tooth disease recessive intermediate C | 2021-11-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002530829 | SCV002938335 | likely pathogenic | Neuronopathy, distal hereditary motor, autosomal recessive 4; Charcot-Marie-Tooth disease recessive intermediate C | 2022-07-25 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 493018). This variant has not been reported in the literature in individuals affected with PLEKHG5-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change affects an acceptor splice site in intron 9 of the PLEKHG5 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in PLEKHG5 are known to be pathogenic (PMID: 17564964, 23777631). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |